Ayala Pharmaceuticals Inc (ADXS)
0.601
-0.02
(-3.22%)
USD |
OTCM |
Apr 16, 16:01
Ayala Pharmaceuticals Cash from Investing (TTM)
Cash from Investing (TTM) Chart
Historical Cash from Investing (TTM) Data
| Date | Value |
|---|---|
| March 31, 2022 | -0.005M |
| December 31, 2021 | -0.005M |
| September 30, 2021 | 0.014M |
| June 30, 2021 | -0.026M |
| March 31, 2021 | -0.001M |
| Date | Value |
|---|---|
| December 31, 2020 | 0.181M |
| September 30, 2020 | -0.481M |
| June 30, 2020 | -0.439M |
| March 31, 2020 | -1.081M |
| December 31, 2019 | -1.581M |
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (TTM) Range, Past 5 Years
-1.581M
Minimum
Dec 2019
0.181M
Maximum
Dec 2020
-0.3424M
Average
-0.0155M
Median
Cash from Investing (TTM) Benchmarks
| Taro Pharmaceutical Industries Ltd | 148.21M |
| InspireMD Inc | -16.09M |
| BiomX Inc | 1.951M |
| Alpha Tau Medical Ltd | -- |
| Pluri Inc | 12.36M |